Cite
MLA Citation
N. G. Daver et al.. “P555: A PHASE 1B/2 STUDY OF THE CD123-TARGETING ANTIBODY-DRUG CONJUGATE PIVEKIMAB SUNIRINE (IMGN632) IN COMBINATION WITH VENETOCLAX (VEN) AND AZACITIDINE (AZA) FOR PATIENTS WITH CD123-POSITIVE AML.” HemaSphere, vol. 6, n.d., pp. 454–455. http://access.bl.uk/ark:/81055/vdc_100159756651.0x000003